PYC Therapeutics Limited (ASX:PYC)
1.740
+0.035 (2.05%)
Jan 16, 2026, 4:10 PM AEST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 1.01 billion as of January 16, 2026. Its market cap has increased by 64.77% in one year.
Market Cap
1.01B
Enterprise Value
863.28M
Revenue
23.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.74
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 1.01B, an increase of 3,518.78%. That is a compound annual growth rate of 18.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.01B | 5.14% |
| Dec 31, 2025 | 965.30M | 56.72% |
| Dec 31, 2024 | 615.92M | 50.00% |
| Dec 29, 2023 | 410.62M | 87.08% |
| Dec 30, 2022 | 219.48M | -48.89% |
| Dec 31, 2021 | 429.43M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.64B |
| Pro Medicus | 22.19B |
| Cochlear | 17.45B |
| Sonic Healthcare | 11.45B |
| Ramsay Health Care | 8.45B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.76B |
| Mesoblast | 3.45B |